Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2025-12-24 @ 11:29 PM
NCT ID:
NCT06624956
Eligibility Criteria:
Inclusion Criteria:
1. Adults 18 years of age or older
2. Patients undergoing abdominal surgery planned to last greater than 4 hours with inpatient admission
3. Patients at UWMC - Montlake
3\. Makes their own medical decisions: patient is deemed to have decisional capacity by the medical team and does not have a surrogate such as a spouse, partner, or caretaker making the decision on their behalf. Examples include patients with severe dementia or other cognitive limitations
Exclusion Criteria:
1. Known diagnosis of diabetes or altered glucose homeostasis during preoperative evaluation (single fasting blood sugar≥126 mg/dL or HbA1C≥6.5 percent).
2. Known diagnosis of chronic kidney disease (moderate-to-severe, or worse)
* BMP within 6 months of screening is required. Patients with stage 3b (moderate-to-severe) kidney disease or worse (i.e. eGFR ≤ 30) will be excluded. Patients with a potassium reading greater than 5.5 at any point within the 6-month period will also be excluded.
3. Patients receiving chronic systemic steroids.
4. Patients undergoing cardiac or solid organ transplant procedures.
5. Surgery planned to last less than 4 hours.
6. Outpatient surgery
7. Pregnant people
8. Current UW Medicine or UW Dentistry residents and fellows
9. Known hypersensitivity to potassium, glucose, insulin, or any of its excipients.
10. Enrollment in another therapeutic study
11. Any serious underlying medical or psychiatric condition, dementia, altered mental status or any issue that would impair the ability of the patient to receive or tolerate the planned treatment, to understand informed consent or that in the opinion of the investigator would contraindicate the patient's participation in the study or that would confound the results of the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06624956
Study Brief:
Protocol Section:
NCT06624956